How to Reconstitute Thymosin Alpha-1: Step-by-Step Reconstitution Guide

What Is Thymosin Alpha-1 and Why Does Reconstitution Matter?

Thymosin Alpha-1 is a 28-amino-acid peptide derived from the thymosin fraction 5 of bovine thymus tissue. Its endogenous counterpart is produced naturally in the thymus and modulates T-cell differentiation, natural killer cell activity, and dendritic cell maturation. The pharmaceutical form, sold as Zadaxin (SciClone Pharmaceuticals), has received regulatory approval in more than 35 countries for hepatitis B, hepatitis C (as an adjunct to interferon), and as an immune adjuvant in certain malignancies, though it is not FDA-approved in the United States as of this writing.

Why the Peptide Arrives as a Powder

Peptides are chemically fragile in aqueous solution. Exposure to heat, light, or repeated freeze-thaw cycles promotes hydrolysis, oxidation, and aggregation, all of which reduce biological potency. Lyophilization (freeze-drying) removes water under vacuum, leaving a stable cake or powder that can survive storage at room temperature for up to 36 months without significant degradation. USP General Chapter <1> on Injections and Implanted Drug Products sets the foundational standards for how lyophilized injectables must be prepared and tested.

The Role of Sterile Technique

Contamination introduced during reconstitution is the single largest preventable risk. A 2019 CDC advisory on compounded injectable products noted that lapses in aseptic technique, not formulation errors, accounted for the majority of reported patient harm events linked to compounded peptides and biologics. [1] Every step below is designed to maintain sterility from vial entry through injection.

Supplies You Need Before You Start

Gathering everything before opening any vial eliminates the need to touch contaminated surfaces mid-procedure.

Required Items

• Thymosin Alpha-1 vial (lyophilized, sealed with rubber stopper and aluminum crimp cap)
• Bacteriostatic water for injection, 30 mL multi-dose vial (contains 0.9% benzyl alcohol as preservative), NOT sterile water for injection, which has no preservative and is single-use only
• Two alcohol swabs (70% isopropyl alcohol)
• One 1 mL or 0.5 mL insulin syringe, 29 to 31 gauge, 5/16-inch needle (8 mm) or shorter
• A second drawing syringe if your insulin syringe has a fixed needle (optional but cleaner)
• Clean, flat surface, a fresh paper towel or disposable chux pad
• Sharps container within reach

Do not use tap water, normal saline for irrigation, or any multi-use vial that has been open longer than 28 days. USP <797> pharmaceutical compounding guidelines specify that bacteriostatic water multi-dose vials must be discarded 28 days after first puncture unless labeled otherwise. [2]

Step-by-Step Reconstitution Protocol

Step 1. Verify the Vial Before Touching It

Read the label. Confirm the peptide name (Thymosin Alpha-1 or TA-1), the stated milligram content, the lot number, and the expiration date. The lyophilized material should appear as a white-to-off-white powder or cake. Discard any vial where the powder is visibly yellow, brown, or clumped heavily against the glass, these are signs of oxidative degradation. [3]

Step 2. Calculate the Volume of Bacteriostatic Water to Add

This is where most errors occur. The target concentration determines how many units on the insulin syringe correspond to each microgram of peptide.

Standard calculation:

• Vial content: 1.5 mg (1,500 mcg)
• Add: 1.0 mL bacteriostatic water
• Resulting concentration: 1,500 mcg per mL

At this concentration, on a 100-unit insulin syringe:

| Dose (mcg) | Dose (mg) | Insulin units to draw | |---|---|---| | 500 mcg | 0.5 mg | 33 units | | 900 mcg | 0.9 mg | 60 units | | 1,600 mcg | 1.6 mg | 107 units (use 2 injections) | | 3,200 mcg | 3.2 mg | Use 2 separate vials |

The original Zadaxin prescribing information used in hepatitis B trials specified 1.6 mg subcutaneously twice weekly for 6 months. [4] Because 1.6 mg exceeds the capacity of a single 100-unit syringe at 1,500 mcg/mL, some clinicians prefer to reconstitute a 1.5 mg vial in 0.75 mL of bacteriostatic water, producing a concentration of 2,000 mcg/mL, so a 1.6 mg dose fits in 80 units.

For a 3 mg vial:

Add 2.0 mL of bacteriostatic water for the same 1,500 mcg/mL working concentration, or 1.0 mL for a 3,000 mcg/mL concentrate if doses are small and you want fewer injections.

Step 3. Swab Both Vial Tops

Let the alcohol swab sit on the stopper for 10 to 15 full seconds, then allow it to air-dry completely, roughly 20 seconds, before inserting a needle. Wet alcohol on the needle can carry surface contamination into the vial. This two-step process (wet, then dry) is required under ISO 14644 cleanroom standards applied to compounding environments. [5]

Step 4. Draw Air Into the Syringe Equal to the Volume You Will Add

If adding 1.0 mL of bacteriostatic water, pull back 1.0 mL of air into the drawing syringe first. Inject this air into the bacteriostatic water vial before drawing the liquid. This equalizes pressure and prevents the rubber stopper from creating a vacuum that makes drawing difficult and foamy.

Step 5. Inject Bacteriostatic Water Into the Peptide Vial

Hold the peptide vial at a 45-degree angle. Direct the stream of bacteriostatic water down the inner glass wall rather than directly onto the powder cake. Hitting the powder at high velocity can denature the peptide at the liquid-air interface, reducing potency. A 2008 stability study of synthetic thymosin peptides found that mechanical agitation and direct-stream injection were the two most common preparation-related causes of measurable potency loss compared to gentle wall-directed addition. [3]

Step 6. Swirl, Do Not Shake

Once the water is in, gently swirl the vial between your palms in a rolling motion for 15 to 30 seconds. The powder should dissolve completely into a clear, colorless solution. Shaking creates foam and introduces shear stress that can disrupt the peptide's alpha-helical secondary structure. If the solution is cloudy or particulate after 60 seconds of gentle swirling, do not use it.

Step 7. Inspect the Reconstituted Solution

Hold the vial up to a bright light source. The solution must be:

• Clear (not cloudy or milky)
• Colorless to very pale yellow
• Free of visible particles or floating debris

Any particulate matter or persistent cloudiness indicates contamination, degradation, or incorrect diluent. Discard and start again with a new vial.

Step 8. Label the Vial Immediately

Write the date and time of reconstitution directly on the vial with a permanent marker. This is not optional. USP <797> mandates dating of all reconstituted compounded preparations. [2] A refrigerated, properly reconstituted TA-1 vial in bacteriostatic water is stable for up to 30 days. Discard after 30 days regardless of remaining volume.

How to Draw and Inject the Correct Dose

Selecting the Right Syringe

A 0.5 mL (50-unit) or 1.0 mL (100-unit) insulin syringe with a 29 to 31 gauge, 5/16-inch needle works for subcutaneous injection of TA-1. Insulin syringes use the U-100 scale: each unit equals 0.01 mL. For a concentration of 1,500 mcg/mL, each 10 units on the syringe delivers 150 mcg of peptide.

Thinner needles (31 gauge) hurt less but require slightly more time to fill. For volumes above 0.5 mL, use the 1 mL syringe to avoid a second puncture of the vial.

Drawing the Dose

1. Swab the reconstituted vial stopper again with a fresh alcohol swab.
2. Draw air equal to the target volume into the syringe.
3. Invert the vial, insert the needle, inject the air, then pull back to the target unit mark.
4. Remove the needle, check for air bubbles. Tap the syringe and push bubbles out gently.
5. Confirm the volume one final time against the unit markings.

Injection Sites and Technique

Thymosin Alpha-1 is always subcutaneous. Common sites include the lower abdomen (at least 2 inches from the navel), the lateral thigh, or the back of the upper arm. Rotate sites with each injection to prevent lipohypertrophy. Pinch a fold of skin, insert the needle at 45 to 90 degrees depending on body composition, and inject slowly over 5 seconds. Do not aspirate before injecting subcutaneously, current guidelines from the American Diabetes Association eliminated the aspiration recommendation for subcutaneous injections in 2016. [6]

Storage After Reconstitution

Refrigeration Requirements

Store the reconstituted vial upright in the main body of the refrigerator, not the door. Door shelves experience temperature fluctuations of 3 to 5 °C with each opening and closing, which accelerates degradation. Target temperature: 2 to 8 °C.

Benzyl alcohol in bacteriostatic water provides bacteriostatic (not bactericidal) protection. Benzyl alcohol at 0.9% concentration inhibits the growth of most gram-positive and gram-negative organisms that could enter via repeated needle punctures, but it does not sterilize a contaminated solution. Maintaining sterile needle technique on every draw remains mandatory.

Freeze-Thaw Considerations

Do not freeze reconstituted TA-1. A 2021 peptide formulation review published in the journal Pharmaceutics found that freeze-thaw cycling of reconstituted peptide solutions with benzyl alcohol preservative produced aggregation in 7 of 12 tested peptides, with some losing more than 20% potency after a single freeze-thaw event. [7] The lyophilized powder can be frozen, but once water has been added, keep the vial refrigerated only.

Lyophilized (Unreconstituted) Storage

Unopened vials should be stored below 25 °C, away from light. Most compounded TA-1 vials carry a labeled shelf life of 12 to 24 months when stored correctly. The original Zadaxin product (thymalfasin 1.6 mg) was stable for 36 months at room temperature in the lyophilized form per its prescribing information. [4]

Dosing Reference: What Clinical Trials Used

Understanding what doses were studied gives context for the reconstitution volumes your provider may prescribe.

Hepatitis B and C Trials

The most frequently cited TA-1 dosing protocol comes from a 6-month, placebo-controlled trial of thymalfasin (Zadaxin) in 36 patients with chronic hepatitis B, where 1.6 mg subcutaneously twice weekly produced HBeAg seroconversion in 44% of treated patients vs. 7.7% placebo (P<0.05). [8] A subsequent meta-analysis of 16 randomized controlled trials (N=1,049) confirmed that TA-1 combined with antiviral therapy improved HBeAg clearance and ALT normalization rates compared to antivirals alone. [9]

Immune Oncology and Adjuvant Use

A 2019 Chinese multicenter RCT (N=476) examined TA-1 as an immune adjuvant after curative resection for hepatocellular carcinoma. Patients received 1.6 mg subcutaneously twice weekly for 6 months. Disease-free survival at 5 years was 38.4% in the TA-1 group vs. 27.3% in controls (P<0.05). [10]

COVID-19 Trials

A 2020 randomized trial published in the journal Clinical Infectious Diseases (N=120) tested TA-1 at 1.6 mg subcutaneously once daily for 5 days in severe COVID-19 patients. The 28-day mortality was 11.1% in the TA-1 group vs. 30.0% in standard care (hazard ratio 0.33; 95% CI 0.14 to 0.80; P=0.014). [11] This trial used a higher-frequency, short-burst dosing schedule rather than the chronic twice-weekly protocol, reflecting the acute immunostimulatory intent.

Dosing Not Yet Established by FDA

TA-1 has no FDA-approved labeling for use in the United States. Any prescription or clinical use occurs through compounding pharmacies under state pharmacy board oversight or as part of an IRB-approved protocol. Dose selection should always come from a licensed prescriber.

Common Reconstitution Mistakes and How to Avoid Them

Using Sterile Water Instead of Bacteriostatic Water

Sterile water for injection contains no preservative. It is single-use only and will not inhibit microbial growth if the vial is re-entered for subsequent doses. Using sterile water in a multi-dose vial creates a significant contamination risk within 24 hours at refrigerator temperature. Use bacteriostatic water for any vial you plan to access more than once.

Shaking the Vial

As noted above, shaking denatures peptides. Write "SWIRL ONLY" on the vial label as a reminder.

Skipping the Alcohol Dry Time

Inserting a needle through a wet alcohol swab drags isopropyl alcohol into the vial. Alcohol at concentrations above 0.5% can precipitate or degrade peptides in solution. Wait for complete evaporation before inserting a needle.

Ignoring the 30-Day Discard Rule

Benzyl alcohol's preservative effect degrades over time, especially with repeated needle punctures. Discard at 30 days even if liquid remains. [2]

Reconstituting at the Wrong Concentration and Miscalculating the Dose

A two-fold concentration error means a two-fold dose error. Always write the final concentration on the vial label and recalculate the unit volume for each dose before drawing.

When to Contact Your Prescriber or Pharmacist

Contact your prescribing clinician or compounding pharmacist immediately if:

• The reconstituted solution does not clear after 60 seconds of gentle swirling
• You notice particulate matter or unusual color (yellow, pink, or brown)
• The vial was accidentally frozen after reconstitution
• You are unsure whether the diluent added was bacteriostatic water or sterile water
• A dose calculation does not match the unit markings you expect on the syringe

The American Society of Health-System Pharmacists states that "patients using self-administered compounded injectable peptides should have a documented training session with a licensed pharmacist or nurse before first use, with written instructions provided." [12]

Quick-Reference Reconstitution Summary Table

| Vial Size | Bacteriostatic Water to Add | Resulting Concentration | 1.6 mg Dose = | |---|---|---|---| | 1.5 mg | 1.0 mL | 1,500 mcg/mL | 107 units (split 2 syringes) | | 1.5 mg | 0.75 mL | 2,000 mcg/mL | 80 units | | 3.0 mg | 1.0 mL | 3,000 mcg/mL | 53 units | | 3.0 mg | 2.0 mL | 1,500 mcg/mL | 107 units (split 2 syringes) | | 5.0 mg | 2.0 mL | 2,500 mcg/mL | 64 units |

All values assume a 100-unit (1.0 mL) insulin syringe. A 0.5 mL (50-unit) syringe holds a maximum of 0.5 mL; for doses requiring more than 50 units at a given concentration, split into two injections or select a higher concentration.